Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
Latest Information Update: 26 Jul 2020
At a glance
- Drugs Regorafenib (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Biomarker; Therapeutic Use
- 06 Oct 2015 New trial record